First Tracks Biotherapeutics, Inc. (TRAX)
31.39
-1.60
(-4.85%)
USD |
NASDAQ |
Oct 06, 16:00
31.50
+0.11
(+0.35%)
Pre-Market: 08:41
First Tracks Biotherapeutics Shareholders Equity (Quarterly) : 168.80M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 168.80M |
| Date | Value |
|---|---|
| March 31, 2026 | 257.46M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Forte Biosciences, Inc. | 183.79M |
| AnaptysBio, Inc. | 10.58M |
| Immunovant, Inc. | 735.39M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Agenus, Inc. | -199.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.14M |
| Total Liabilities (Quarterly) | 14.34M |
| Debt to Equity Ratio | 0.0257 |
| Current Ratio | 14.28 |
| Net Debt Paydown Yield | -0.15% |